South Korea Biotech News - Latest Updates & Headlines
Samsung Biologics to invest USD 4.8 billion in new Songdo bio campus
New Delhi, December 2: Samsung Biologics has announced a massive investment of 7 trillion won (about USD 4.8 billion) to build its third bio campus in Songdo, Incheon, marking another step toward expanding its global biopharmaceutical production and advancing next-generation drug manufacturing technologies, as per a report by Pulse, the English service of Maeil Business News Korea.
S. Korea's biotech industry output rises 9.8 pc despite global uncertainty
Seoul, Nov 11: South Korea's biotechnology industry output grew nearly 10 per cent in 2024 from a year earlier despite persistent global trade uncertainties, industry data showed on Tuesday.
Samsung Biologics signs $1.29 billion deal with US pharma firm
Seoul, Sep 9: Samsung Biologics, South Korea's leading biotech firm, said on Tuesday it has secured a 1.8 trillion-won ($1.29 billion) contract to provide manufacturing services for a U.S. pharmaceutical company through 2029.
S. Korea discusses AI-powered drug development amid growing global competition
Seoul, May 15: The South Korean government on Thursday held a consultative meeting with private sector stakeholders to promote the use of artificial intelligence (AI) in drug development in response to the intensifying global competition in the bio-health sector.
S. Korea's bio industry urges US to exempt it from proposed pharmaceutical tariffs
Seoul, May 7: The Korea Biotechnology Industry Organization (KBIO) on Wednesday said it has requested the US to exempt South Korea from the Donald Trump administration's plan to impose tariffs on pharmaceutical imports.